Michael Petusky
Stock Analyst at Barrington Research
(2.53)
# 1,367
Out of 4,667 analysts
168
Total ratings
48.03%
Success rate
-0.2%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MODV ModivCare | Maintains: Outperform | $25 | $16.31 | +53.28% | 12 | Nov 18, 2024 | |
| VRME VerifyMe | Maintains: Outperform | $1.5 | $0.75 | +100.27% | 8 | Nov 13, 2024 | |
| HAE Haemonetics | Maintains: Outperform | $108 | $84.96 | +27.13% | 26 | Nov 8, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Outperform | $36 → $24 | $18.52 | +29.59% | 19 | Nov 8, 2024 | |
| USPH U.S. Physical Therapy | Maintains: Outperform | $108 | $94.06 | +14.82% | 20 | Nov 7, 2024 | |
| HSIC Henry Schein | Maintains: Outperform | $82 | $73.73 | +11.22% | 11 | Nov 6, 2024 | |
| LMAT LeMaitre Vascular | Maintains: Outperform | $92 → $93 | $103.44 | -10.09% | 8 | Nov 1, 2024 | |
| ANIK Anika Therapeutics | Maintains: Outperform | $37 → $25 | $17.18 | +45.52% | 15 | Nov 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $114 | $104.08 | +9.53% | 15 | Oct 31, 2024 | |
| OPCH Option Care Health | Maintains: Outperform | $40 → $32 | $21.88 | +46.25% | 11 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $2.25 | $1.58 | +42.41% | 10 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $7.48 | - | 6 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $39.17 | - | 6 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.59 | - | 1 | Jul 27, 2021 |
ModivCare
Nov 18, 2024
Maintains: Outperform
Price Target: $25
Current: $16.31
Upside: +53.28%
VerifyMe
Nov 13, 2024
Maintains: Outperform
Price Target: $1.5
Current: $0.75
Upside: +100.27%
Haemonetics
Nov 8, 2024
Maintains: Outperform
Price Target: $108
Current: $84.96
Upside: +27.13%
DENTSPLY SIRONA
Nov 8, 2024
Maintains: Outperform
Price Target: $36 → $24
Current: $18.52
Upside: +29.59%
U.S. Physical Therapy
Nov 7, 2024
Maintains: Outperform
Price Target: $108
Current: $94.06
Upside: +14.82%
Henry Schein
Nov 6, 2024
Maintains: Outperform
Price Target: $82
Current: $73.73
Upside: +11.22%
LeMaitre Vascular
Nov 1, 2024
Maintains: Outperform
Price Target: $92 → $93
Current: $103.44
Upside: -10.09%
Anika Therapeutics
Nov 1, 2024
Maintains: Outperform
Price Target: $37 → $25
Current: $17.18
Upside: +45.52%
Merit Medical Systems
Oct 31, 2024
Maintains: Outperform
Price Target: $114
Current: $104.08
Upside: +9.53%
Option Care Health
Oct 31, 2024
Maintains: Outperform
Price Target: $40 → $32
Current: $21.88
Upside: +46.25%
Sep 20, 2024
Maintains: Outperform
Price Target: $2.25
Current: $1.58
Upside: +42.41%
Aug 28, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $7.48
Upside: -
May 30, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $39.17
Upside: -
Jul 27, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $1.59
Upside: -